Table 1.
LFS 95% CI |
OS 95% CI |
|||||||
---|---|---|---|---|---|---|---|---|
Variable | HR | Lower | Upper | P | HR | Lower | Upper | P |
DIPSS-plusa | 1.984 | 0.981 | 4.012 | 0.057 | 2.034 | 0.983 | 4.212 | 0.056 |
ASXL1/JAK2 allele burdenb | 2.061 | 1.015 | 4.186 | 0.045 | 2.361 | 1.206 | 4.624 | 0.012 |
EZH2 | 1.932 | 0.456 | 8.181 | 0.371 | 1.567 | 0.384 | 6.388 | 0.531 |
SRSF2 | 2.074 | 0.414 | 10.394 | 0.375 | 1.504 | 0.324 | 6.979 | 0.602 |
IDH | 2.319 | 0.079 | 68.062 | 0.626 | 4.134 | 0.152 | 112.1 | 0.399 |
P values < 0.05 are considered statistically significant.
HMR high-molecular risk, HR hazard ratios, CI confidence interval.
aDIPSS-plus: low vs. intermediate-1 vs. intermediate-2 vs. high-risk groups.
bASXL1 mutation with low JAK2 allele burden (<75%) versus others.